Rafael Holdings, Inc. (RFL): Capital Expenditures

Annual figures by period end, from SEC filings.

$3.0K
Year ended 2026-07-31
-57.1%
5-year compound annual growth
-46.5%
10-year compound annual growth
$1.82M2016-07-31: $1.55M2017-07-31: $1.82M2018-07-31: $710.0K2019-07-31: $399.0K2020-07-31: $534.0K2021-07-31: $206.0K2022-07-31: $2.0K2024-07-31: $143.0K2025-07-31: $4.0K2026-07-31: $3.0K$3.0K
2016-07-31 Capital Expenditures (USD) 2026-07-31
Period endedCapital ExpendituresChange YoYSource filing
2026-07-31$3.0K-25.0%2026-10-29, From 2025-08-01
2025-07-31$4.0K-97.2%2026-10-29, From 2024-08-01
2024-07-31$143.0Kn/a2025-10-29, From 2023-08-01
No annual figure between 2022-07-31 and 2024-07-31.
2022-07-31$2.0K-99.0%2023-10-30, From 2021-08-01
2021-07-31$206.0K-61.4%2021-10-18, From 2020-08-01
2020-07-31$534.0K+33.8%2021-10-18, From 2019-08-01
2019-07-31$399.0K-43.8%2020-10-29, From 2018-08-01
2018-07-31$710.0K-61.0%2019-10-04, From 2017-08-01
2017-07-31$1.82M+17.2%2018-10-15, From 2016-08-01
2016-07-31$1.55Mn/a2018-10-15, From 2015-08-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Rafael Holdings, Inc. (RFL)2026-07-31$3.0K-25.0%
Shattuck Labs, Inc. (STTK)2025-12-31$71.0K+20.3%
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$139.9K+34.8%
Dare Bioscience, Inc. (DARE)2025-12-31$385.3K-32.8%
Lexaria Bioscience Corp. (LEXX)2025-08-31$24.6K-42.7%
BioXcel Therapeutics, Inc. (BTAIQ)2025-12-31$0n/a
Longeveron Inc. (LGVN)2025-12-31$245.0K-62.6%
PMGC Holdings Inc. (ELAB)2025-12-31$442.3Kn/m
Yarrow Bioscience, Inc. (YARW)2025-12-31$0-100.0%

Compare RFL, STTK, SXTP, DARE side by side · Screen every company in Pharmaceutical Preparations ↗